000 01359 a2200373 4500
005 20250518001317.0
264 0 _c20190923
008 201909s 0 0 eng d
022 _a1365-2796
024 7 _a10.1111/joim.12838
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPetek, B
245 0 0 _aConnecting the brain cholesterol and renin-angiotensin systems: potential role of statins and RAS-modifying medications in dementia.
_h[electronic resource]
260 _bJournal of internal medicine
_c12 2018
300 _a620-642 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aBrain
_xmetabolism
650 0 4 _aCholesterol
_xmetabolism
650 0 4 _aCognition
_xdrug effects
650 0 4 _aDementia
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aHydroxymethylglutaryl-CoA Reductase Inhibitors
_xtherapeutic use
650 0 4 _aRenin-Angiotensin System
_xdrug effects
700 1 _aVilla-Lopez, M
700 1 _aLoera-Valencia, R
700 1 _aGerenu, G
700 1 _aWinblad, B
700 1 _aKramberger, M G
700 1 _aIsmail, M-A-M
700 1 _aEriksdotter, M
700 1 _aGarcia-Ptacek, S
773 0 _tJournal of internal medicine
_gvol. 284
_gno. 6
_gp. 620-642
856 4 0 _uhttps://doi.org/10.1111/joim.12838
_zAvailable from publisher's website
999 _c28883913
_d28883913